Echocardiogram
Echocardiogram is an intervention with 78 clinical trials. Currently 25 active trials ongoing. Historical success rate of 87.9%.
Success Metrics
Based on 29 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
4
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.3%
29 of 38 finished
23.7%
9 ended early
25
trials recruiting
78
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
Clinical Trials (78)
Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer
A Study of Blood Pressure Control During Cancer Treatment
The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field
Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction
Next Generation Personalized Neuroblastoma Therapy
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As Children
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration
London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Assessment of Cardiac Output and Stroke Volume in Septic Shock Patients
Leveraging Exercise Stress Echocardiography for Heart Failure With Preserved Ejection Fraction
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
Beta-blocker Administration for Cardiomyocyte Division
A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 78